Literature DB >> 17102062

Placebo/nocebo symptom reporting in a sham herbal supplement trial.

Jessica Link1, Rob Haggard, Kimberly Kelly, Dan Forrer.   

Abstract

The present study examined reports of placebo and nocebo symptoms in a college sample. The study was presented under the guise of a clinical trial to evaluate the effectiveness of an over-the-counter herbal supplement intended to enhance cognitive performance. Participants were informed they would be receiving either an herbal supplement or a placebo, and each was provided with a mock list of possible beneficial and adverse effects of the "supplement." In fact, all participants received placebo. Symptoms were endorsed by a significant majority of participants following placebo ingestion. More important, results indicated that the few participants who believed they received an herbal supplement endorsed (via self-report) significantly more symptoms than those who believed they received a placebo. Neither anxiety nor social desirability was significantly related to symptom reporting. Results suggest that beliefs concerning treatment received may subsequently affect the degree of placebo response in a no-treatment group. Implications for clinical trials and future research are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102062     DOI: 10.1177/0163278706293403

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  7 in total

Review 1.  Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors:  Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  The placebo effect, sleep difficulty, and side effects: a balanced placebo model.

Authors:  Nadine Neukirch; Ben Colagiuri
Journal:  J Behav Med       Date:  2014-08-14

Review 3.  Lessons learned from placebo groups in antidepressant trials.

Authors:  Meike Shedden Mora; Yvonne Nestoriuc; Winfried Rief
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Authors:  Malin Alenius; Margareta Hammarlund-Udenaes; Per Hartvig; Leif Lindström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-21       Impact factor: 4.328

5.  Minimizing Drug Adverse Events by Informing About the Nocebo Effect-An Experimental Study.

Authors:  Yiqi Pan; Timm Kinitz; Marin Stapic; Yvonne Nestoriuc
Journal:  Front Psychiatry       Date:  2019-07-25       Impact factor: 4.157

6.  Herbal medicine for the treatment of chronic rhinosinusitis: A systematic review and meta-analysis.

Authors:  Boram Lee; Chan-Young Kwon; Man Young Park
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

7.  Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial.

Authors:  Michael Teut; Joern Dahler; Ute Hirschberg; Rainer Luedtke; Henning Albrecht; Claudia M Witt
Journal:  Trials       Date:  2013-04-05       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.